MEGAN KERA: Open Payments
NPI 1467892752 · MONTCLAIR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,249 in 226 payments from 21 companies in 2025. Trend: 2023 $2,424 · 2024 $3,033 · 2025 $3,249
Food & beverage: $3,095Education: $154
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $483 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 31 | $339 |
| Janssen Biotech, Inc. | 15 | $309 |
| LEO Pharma Inc. | 18 | $269 |
| PFIZER INC. | 15 | $248 |
| Incyte Corporation | 13 | $217 |
| Galderma Laboratories, L.P. | 14 | $185 |
| Arcutis Biotherapeutics, Inc. | 21 | $185 |
| Almirall LLC | 20 | $160 |
| Novartis Pharmaceuticals Corporation | 6 | $145 |
Products named: TREMFYA, ADBRY, ILUMYA, OPZELURA, CIBINQO, Zoryve, RINVOQ, Klisyri.
Industry payments across NJ — which companies pay providers there.
